Trial intelligence / Profile preview

Verapamil versus metoprolol for prevention of atrial fibrillation progression

NL-OMON27565Phase 4Withdrawn

Sponsor
Martini Ziekenhuis
Start
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of verapamil and metoprolol, sponsored by Martini Ziekenhuis. Planned start Dec 2018; status: withdrawn.

02

Drugs

verapamilmetoprolol

Beyond the preview

Go deeper on NL-OMON27565.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON27565.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call